Potential Benefits of Expanded Palivizumab in American Indian Children Under the Age of 2 Years
Ryan M Close1, Alvin S Palmer1, James B McAuley1
1Whiteriver Service Unit, Indian Health Service, Whiteriver, Arizona, USA.
Insights
Expanding palivizumab to all young children significantly reduced respiratory syncytial virus (RSV) infections and hospitalizations in an American Indian community. This intervention benefited both high-risk and non-high-risk infants, demonstrating broad public health impact.
Area of Science:
- Public Health
- Pediatrics
- Infectious Diseases
Background:
- Severe respiratory syncytial virus (RSV) disproportionately affects American Indian communities.
- RSV is a leading cause of lower respiratory tract infections in infants.
Purpose of the Study:
- To evaluate the impact of expanded palivizumab prophylaxis on RSV infections and hospitalizations in a rural American Indian community.
- To assess the effectiveness of universal palivizumab use in infants under two years of age.
Main Methods:
- Implementation of an expanded palivizumab program for all children under two years of age.
- Retrospective analysis of RSV infection and hospitalization rates before and after program implementation.
- Inclusion of both high-risk and non-high-risk infants in the analysis.
Main Results:
- Significant reductions in RSV infections were observed across the community.
- Hospitalization rates for RSV decreased significantly among infants receiving palivizumab.
- The program demonstrated effectiveness in both high-risk and non-high-risk infant populations.
Conclusions:
- Expanded palivizumab prophylaxis is an effective strategy to reduce the burden of RSV in American Indian communities.
- Universal palivizumab access can mitigate disparities in severe RSV outcomes.
- Public health programs targeting vulnerable populations can yield substantial health benefits.
Abstract:
Severe respiratory syncytial virus (RSV) infections disparately impact American Indian communities. We implemented a program that expanded palivizumab to all children under 2 years of age that led to significant reductions in RSV infections and hospitalizations for both high-risk and non-high-risk recipients in a rural American Indian community in Eastern Arizona.
More Related Videos
09:14An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
01:51Vaccinations
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Asthma-IV: Nursing Management
First, in...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....